Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 34Active not recruiting 15Recruiting 13Terminated 12Unknown 6Not yet recruiting 3Withdrawn 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Melanoma 3Carcinoma, Non-Small-Cell Lung 3Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Turcot syndrome 1Sarcoma 1Post-Acute COVID-19 Syndrome 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Clear-cell metastatic renal cell carcinoma 1Carcinoma 1Advanced Kidney Cancer 1

Interventions

Carboplatin 34Pemetrexed 27Drug Therapy 22Cisplatin 22osimertinib 18aflutinib 11Paclitaxel 11pembrolizumab 10Surgical Procedures, Operative 10Docetaxel 10tislelizumab 9Radiotherapy 8Magnetic Resonance Spectroscopy 8anlotinib 7Specimen Handling 7Bevacizumab 7130-nm albumin-bound paclitaxel 7toripalimab 6cemiplimab 6Immunotherapy 6sintilimab 5ensartinib 5durvalumab 5Radiosurgery 5Platinum Compounds 5Nivolumab 5trametinib 4aumolertinib 4Observation 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Non-Small-Cell Lung × Ipilimumab × Clear all
NCT07355205 2026-05-22

FLINN

Washington University School of Medicine

Phase 2 Not yet recruiting
26 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07603856 2026-05-22

REVIVE

University of Chicago

Phase 2 Not yet recruiting
39 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05597800 2022-10-28

LUNGVIR

Universita di Verona

Phase 2 Not yet recruiting
105 enrolled
Thoracic

Post-Acute COVID-19 Syndrome, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡